Kepos Capital’s Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares BIOX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-583,678
Closed -$123K 347
2020
Q2
$123K Hold
583,678
0.02% 183
2020
Q1
$82K Hold
583,678
0.02% 153
2019
Q4
$93K Sell
583,678
-101,200
-15% -$31.2K 0.01% 345
2019
Q3
$233K Sell
684,878
-285,522
-29% -$108K 0.02% 265
2019
Q2
$320K Sell
970,400
-10,000
-1% -$2.31K 0.03% 258
2019
Q1
$265K Buy
+980,400
New +$235K 0.02% 308

Kepos Capital's BIOX.WS Position: Q3 2020 in Review

Kepos Capital sold out of Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares (BIOX.WS) in Q3 2020, closing a stake of 583,678 shares — an estimated $123K sold.

Kepos Capital first reported a position in BIOX.WS in Q1 2019 and held it in 6 quarters. The position peaked at $320K in Q2 2019. 0 funds tracked by Wall St. Rank hold BIOX.WS as of Q3 2020.

  • Kepos Capital reported no remaining Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares position as of Q3 2020 after selling out during the quarter.
  • Kepos Capital sold 583,678 Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares shares in Q3 2020, an estimated $123K.
  • Kepos Capital first reported a position in Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares in Q1 2019 and held it in 6 quarters.
  • Kepos Capital's Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares position peaked at $320K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares as of Q3 2020.

Based on Kepos Capital's 13F filing for Q3 2020, filed 13 Nov 2020.